Carl Zeiss Meditec AG (fra:AFXA) Share Price

Company Profile

Business description
Carl Zeiss Meditec is one of the largest visioncare technology companies in the world. Its ophthalmology segment, which made up about 75% of sales in 2025, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, intraocular lenses, and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. The microsurgery segment is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% share, Zeiss is the clear leader in this market.
Contact
Goschwitzer Strasse 51-52
JenaTH07745
DEU
T: +49 3641220115
https://www.zeiss.com
Sector
Healthcare
Stock type
Defensive
Industry
Medical Instruments & Supplies
Fiscal Year End
30 September 2027
Employees
5,798

Recommended

These shares are trading at a discount to our fair value discount and have sustainable competitive advantages.

Morningstar | 11 November 2026

There may be meaningful upside as Anthropic is pricing its stock as a reflection of current sentiment, not the company’s fundamentals.

Malik Ahmed Khan, CFA | 11 November 2026

Strong fundamentals meet a demanding valuation.

Esther Holloway | 11 November 2026

Index	Last price	Change	% Change
All Ordinaries	9,243.40	47.90	-0.52%
CAC 40	8,332.87	54.28	0.66%
DAX 40	26,662.77	315.32	1.20%
Dow JONES (US)	52,486.49	254.60	0.49%
FTSE 100	10,835.47	83.88	0.78%
HKSE	24,044.48	271.44	-1.12%
NASDAQ	25,466.19	400.32	1.60%
Nikkei 225	61,592.02	343.43	0.56%
NZX 50 Index	14,256.38	76.52	0.54%
S&P 500	7,619.38	98.45	1.31%
S&P/ASX 200	9,111.10	42.10	-0.46%
SSE Composite Index	3,681.69	1.04	0.03%